FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

425128001: Product containing antazoline and xylometazoline (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3523873011 Product containing antazoline and xylometazoline (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3713237012 Antazoline- and xylometazoline-containing product en Synonym Active Entire term case insensitive SNOMED CT core module


5 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing antazoline and xylometazoline Is a Product containing xylometazoline true Inferred relationship Existential restriction modifier
Product containing antazoline and xylometazoline Is a Product containing antazoline true Inferred relationship Existential restriction modifier
Product containing antazoline and xylometazoline Has active ingredient Xylometazoline hydrochloride false Inferred relationship Existential restriction modifier
Product containing antazoline and xylometazoline Has active ingredient Antazoline true Inferred relationship Existential restriction modifier 2
Product containing antazoline and xylometazoline Is a Product containing xylometazoline in ophthalmic dosage form false Inferred relationship Existential restriction modifier
Product containing antazoline and xylometazoline Has manufactured dose form Ocular dose form false Inferred relationship Existential restriction modifier
Product containing antazoline and xylometazoline Has active ingredient Xylometazoline true Inferred relationship Existential restriction modifier 1
Product containing antazoline and xylometazoline Is a Virtual therapeutic moiety false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops Is a False Product containing antazoline and xylometazoline Inferred relationship Existential restriction modifier
Product containing antazoline and xylometazoline in ocular dose form (medicinal product form) Is a True Product containing antazoline and xylometazoline Inferred relationship Existential restriction modifier
Antazoline + Xylometazoline Is a True Product containing antazoline and xylometazoline Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start